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a  b  s  t  r  a  c  t
More  than  85%  of  all human  cancers  possess  the  ability  to maintain  chromosome  ends,  or  telomeres,  by
virtue of telomerase  activity.  Loss  of  functional  telomeres  is incompatible  with  survival,  and  telomerase
inhibition  has  been  established  in  several  model  systems  to be  a  tractable  target  for  cancer  therapy.  As
human  tumour  cells  typically  maintain  short  equilibrium  telomere  lengths,  we  wondered  if enforced
telomere  elongation  would  positively  or negatively  impact  cell  survival.  We  found  that  telomere  elon-
gation  beyond  a certain  length  signiﬁcantly  decreased  cell  clonogenic  survival  after  gamma  irradiation.eywords:
elomeres
elomerase
uman tumour cells
amma  irradiation
Susceptibility  to irradiation  was  dosage-dependent  and  increased  at telomere  lengths  exceeding  17 kbp
despite  the  fact  that  all chromosome  ends  retained  telomeric  DNA.  These  data  suggest  that  an  optimal
telomere  length  may  promote  human  cancer  cell  survival  in  the  presence  of genotoxic  stress.
© 2014  The  Authors.  Published  by Elsevier  B.V.  This  is  an open  access  article  under  the  CC  BY-NC-SA
license  (http://creativecommons.org/licenses/by-nc-sa/3.0/).NA damage
. Introduction
The acquisition of telomerase reverse transcriptase (TERT)
xpression and its ability, together with the telomerase RNA, to
aintain telomeres at chromosome ends is one of the hallmarks of
ancer [1]. In the absence of telomerase function or upon enforced
elomerase inhibition, telomere erosion eventually results in a
elomere-speciﬁc DNA damage response that leads to chromo-
ome end resection, loss, or fusion, and anaphase bridges (reviewed
n [2,3,4]). Short telomeres, which are typical of human cancer
ells [5,6], are a preferential substrate for telomere elongation by
elomerase in many model systems. Indeed, the levels of the telo-
erase components TERT and its integral RNA, hTR, are limiting in
any cell types including cancer cells (reviewed in [7]). Conversely,
Abbreviations: ALT, alternative lengthening of telomeres; ANOVA, analysis of
ariance; CST, CTC1, STN1 and TEN1 complex; DSB, double-stranded DNA break;
TR, human telomerase RNA; PDL, population doubling level; PE, plating efﬁciency;
-FISH, quantitative ﬂuorescence in situ hybridization; SF, survival fraction; SFE,
ignal-free end; SV40, simian virus 40; TERT, telomerase reverse transcriptase; TRF,
elomere restriction fragment.
∗ Corresponding author at: Institute for Research in Immunology and Cancer,
epartment of Medicine, University of Montreal, 2950 chemin de Polytechnique,
ontreal, Canada H3T 1J4. Tel.: +1 514 343 6729.
E-mail address: lea.harrington@umontreal.ca (L. Harrington).
ttp://dx.doi.org/10.1016/j.dnarep.2014.11.005
568-7864/© 2014 The Authors. Published by Elsevier B.V. This is an open access article unlong telomeres inhibit access by telomerase, and in some instances
excessively elongated telomeres are actively trimmed by complex
recombination mechanisms [8–12] (reviewed in [13,14]). Thus, in
many cell types, the homeostatic balance between these processes
ensures that telomere length is maintained around a given equi-
librium telomere length. We questioned why  tumour cells tend to
maintain short average telomere lengths, and whether long telom-
eres might be disadvantageous for cell survival in the presence of
DNA damage.
2. Materials and methods
2.1. Cell culture and cell irradiation
Cell culture and population doubling level (PDL) calculations
were performed as described [15]. Irradiation experiments were
carried out according to Boyd et al. [16]. Cells were seeded in 25 cm2
ﬂasks at a concentration of 1 × 105 cells/ﬂask. After 24 h adherent
cells were irradiated at a range of doses from 0 to 10 Gy using a 60Co
irradiator, returned to a 37 ◦C incubator for 24 h, then resuspended
in 0.5% w/v trypsin solution and counted on a haemocytometer.
Cells were plated in triplicate at 2.5 × 103 per 75 cm2 ﬂask and incu-
bated at 37 ◦C for 7–10 days. Cells were ﬁxed and stained with 10%
w/v crystal violet in methanol. Clusters of approximately 50 or more
der the CC BY-NC-SA license (http://creativecommons.org/licenses/by-nc-sa/3.0/).
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ells were scored as a single colony. The SF was calculated by deter-
ining the plating efﬁciency (PE, deﬁned as the number of colonies
ivided by the number of cells seeded), with the ﬁrst PE value at
 Gy (of n = 3) normalized to 1.0. Thus, the average SF at 0 Gy is near
but not exactly equal to) 1.0, and the SF of cells exposed to irradia-
ion are expressed relative to the SF at 0 Gy. All the cell lines in each
raph were subjected to irradiation and subsequent manipulations
t the same time. Statistical analysis was carried out using Prism
.0 (GraphPad, Inc.), in which the SF values (at least n = 3) of a cell
ine at a given irradiation dosage were assigned to a single column
e.g. in Fig. 2A, left, there were 12 columns, representing SF values
or 17 PDL and 146 PDL lines at 0, 2, 4, 6, 8, and 10 Gy, respectively).
ll columns were compared simultaneously using one-way ANOVA
parametric, unmatched observations) followed by a Tukey post-
est. The calculated p-values shown represent level of signiﬁcance
** p < 0.01; *** p < 0.001) of a given PDL at a particular irradia-
ion dosage relative to the earliest PDL at the same irradiation
osage.
.2. Telomere length measurements
Q-FISH analysis and Southern blots to assess telomere length
ere performed as described previously [15]. Q-FISH analysis
mployed an automated Metafer Slide Scanning platform (Meta-
ystems, Inc.) capable of automated analysis of 8 slides under
dentical conditions. Unless otherwise stated, Q-FISH proﬁles
hown in the same ﬁgure panel were analyzed simultaneously in
his manner. Average telomere lengths at a given PDL were deter-
ined via linear regression analysis of average telomere signal
ntensity obtained via 3 independent Q-FISH measurements ver-
ﬁed against TRF length determined by southern blot where a.u.
y) were converted to kbp (x) using the formula y = 64x − 106. This
inear regression analysis yielded an R-squared co-efﬁcient of 0.97
data not shown). In Fig. 1C, signal-free ends were deﬁned as chro-
osome ends that yielded no detectable telomere ﬂuorescence
ignal, from a total of 920 ends analyzed for each sample; the data
rom one representative experiment is shown (n = 3). p-values of
 < 0.05 (*) or p < 0.0001 (****) were calculated using Fisher’s exact
est (Prism 5.0, GraphPad Inc.).
. Results
.1. Prolonged TERT expression and its effect upon telomere
ength and integrity
In a previous study, we generated and characterized human
umour cell lines derived from a human embryonic kidney parental
ine containing the SV40 early region and oncogenic Ras, that
ither expressed exogenous TERT, possessed telomerase activity,
nd underwent telomere elongation (TERT-positive) or had TERT
xcised, lost telomerase activity, and underwent telomere erosion
TERT-excised) [17]. TERT-excised cells remained viable and capa-
le of tumour formation for prolonged periods, and succumbed to
poptosis only upon signiﬁcant accumulation of telomere signal-
ree ends [17]. In this study, we separately propagated these cell
ines with or without TERT, in order to enable an assessment
f relative DNA damage sensitivity of clonal isolates that were
erived from the same parental line. In TERT-positive tumour cells
etween population doubling levels of 11 and 169, the mean telo-
ere length continuously increased from 12 kbp to 24 kbp (Fig. 1A).
elomere elongation was assessed in two independently derived
ERT-positive clones and telomere length increased by 54–76 bp
er PDL (Fig. 1A and B, data not shown). In two other clonal lines,
ERT was excised and the rate of telomere erosion ranged between
5 and 38 bp per PDL (Fig. 1A and B, data not shown). As expected,epair 25 (2015) 54–59 55
the frequency of telomere signal-free ends correlated positively
with the acquisition of very short telomeres (Fig. 1C and D). TERT-
positive cells, on the other hand, exhibited a statistically signiﬁcant
decrease and eventual elimination in the incidence of SFE as aver-
age telomere lengths increased (Fig. 1C and D). TERT-positive cells
at late passages also did not exhibit evidence of extensive telo-
mere trimming, as judged by the absence of accumulation of shorter
telomeres (Fig. 1A: e.g. compare Q-FISH proﬁles in Vec-1 line at PDL
11 and 169).
3.2. The impact of telomere elongation upon survival after
gamma irradiation
We tested the impact of telomere length on the response to ion-
izing radiation in two  independently generated TERT-positive and
TERT-excised cell populations. Without irradiation, all cell types
exhibited an equivalent ability to form colonies regardless of telo-
mere length or telomerase status (Fig. 2A, data not shown). Also as
expected, at high irradiation doses (8–10 Gy) all cell types under-
went signiﬁcant cell death, with a low or zero survival fraction (SF)
(Fig. 2A and B). After exposure to intermediate dosages of irradia-
tion (2–6 Gy), TERT-excised cell populations with short telomeres
exhibited a signiﬁcant and dosage-dependent decline in SF rela-
tive to the same cell line with longer telomeres (Fig. 2A and B,
right; compare blue lines at increasing PDL). The decreased survival
of cells with short telomeres after exposure to gamma  radiation
is in keeping with previous studies showing that short telomeres
and DNA damaging agents act synergistically to induce apoptosis
[18–25]. However, cell populations with telomeres over 17 kbp in
length also demonstrated a statistically signiﬁcant decrease in SF
at intermediate doses of gamma irradiation (Fig. 2A and B, left;
compare orange lines at increasing PDL). Speciﬁcally, two inde-
pendently derived TERT-positive cell clones with TRF lengths of
approximately 24 or 20 kbp (Fig. 2A; 153 and 146 PDL, respectively)
exhibited a signiﬁcant decrease in SF after exposure to 4 or 6 Gy irra-
diation, compared with the same clones with TRF lengths of 12 or
13 kbp (Fig. 2A; 11 and 17 PDL, respectively). This observation was
reproduced in another independent experimental series, where
TERT-positive populations (PDL 58, 17 kbp; or PDL  142, 20 kbp)
exhibited a statistically signiﬁcant decrease in SF at 4 Gy or 6 Gy
compared to the same population with shorter telomeres (PDL 15,
13 kbp) (Fig. 2B). This difference did not appear to be a function of
the inherent ability to respond to DNA damage, since we observed
similar levels of 53BP1 and -H2AX foci in untreated cells and in foci
induction after one hour of exposure to 10 Gy in all TERT-positive
lines, regardless of telomere length (data not shown). A plot of sur-
vival fraction against average telomere length demonstrated that
average telomere lengths of >12 kbp or <17 kbp yielded a maximal
SF across a range of sub-lethal irradiation doses using two indepen-
dently derived datasets (Fig. 2C and D derived from data in Fig. 2A
and B, respectively). This data demonstrates that an optimal range
of telomere lengths was  associated with an increased resistance to
irradiation.
4. Discussion and conclusions
The mechanisms that lead to an increased irradiation sensitiv-
ity of cells with very long telomeres may  be different than cells
with very short telomeres. In primary cells where telomeres are
critically short and thus possess signal-free ends, the presence of
telomerase activity – accompanied by telomere elongation – res-
cues cells from the deleterious effects of ionizing radiation [26].
Similarly, the reactivation of telomerase and telomere elongation in
a murine cancer model with critically short telomeres leads to rapid
tumour progression [27,28], and TERT promoter mutations have
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Fig. 1. Telomere length and integrity in human tumour cell lines of varying telomere lengths and TERT status. Four independent clones from the same parental line in which
(A)  TERT was not excised and cells remained telomerase-positive (TERT-positive; Vec-1, Vec-2) or (B) TERT was excised and cells became telomerase-negative (TERT-excised;
Cre-1, Cre-4), were propagated for the population doubling levels indicated (PDL, in red), and quantiﬁed for telomere signal intensity using Q-FISH. y-Axis, frequency of events;
x-axis,  telomere signal intensity in arbitrary units; each tick represents events across 50 a.u. (each 1000 a.u. marked as indicated). The scales for all graphs are equivalent; the
y-axis labels are shown only for the top two graphs. Red arrows indicate average telomere length (see Section 2). (C) The percentage of chromosome ends lacking a telomere
signal  in metaphase preparations (as in A and B). y-Axis, percentage of telomere signal-free ends (total: 920 per sample); x-axis, labels as in (A), with earliest PDL  at left. One
representative experiment (of n = 3) shown where all samples were analyzed under identical conditions using an automated Metafer system. * p < 0.05, **** p < 0.001 (Fisher’s
e ples) 
x r in th
b
t
o
t
p
n
t
dxact  test). (D) The incidence of telomere signal-free ends (total n = 920 for all sam
-axis, average telomere length in kbp. (For interpretation of the references to colo
een identiﬁed in melanoma and other aggressive human cancer
ypes (reviewed in [29,30]). In these instances, telomere elongation
ccurs in a context where telomeres are initially short, and thus
elomerase induction may  permit SFE repair. However, in TERT-
ositive tumour cells with telomeres exceeding 17 kbp, there were
o detectable SFE prior to irradiation, suggesting that the sensi-
izing mechanism(s) are SFE-independent. This observation is also
istinct from telomere damage induced by oxidative stress, whichas a function of telomere length. y-Axis, log10 of the incidence of signal-free ends;
is ﬁgure legend, the reader is referred to the web version of this article.)
is cumulative across increasing telomere lengths (6–9 kbp) despite
the fact that sensitivity to ionizing radiation remained constant
[26].
Further study is necessary to determine the exact mechanisms
that lead to the irradiation vulnerability of cells with long telom-
eres. In the absence of DNA damage, TERT-positive cells with very
long telomeres did not exhibit a difference in clonogenic survival
compared with TERT-positive cells with shorter telomeres (Fig. 2,
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Fig. 2. Tumour cell viability after treatment with ionizing radiation. (A) Independently derived TERT-positive (Vec-1, Vec-2) or TERT-excised lines (Cre-4, Cre-1) (as in Fig. 1A)
were  subjected to 0–10 Gy ionizing radiation and analyzed for clonogenic survival (see Section 2 for details). (B) A third representative experiment with a TERT-positive
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ength, using the data shown in panel (B), to demonstrate that the maximal SF occuata not shown), and we showed previously that tumour forma-
ion in a xenograft model was comparable regardless of telomere
ength [17]. ALT cells are telomerase-negative, tumour-forming
ells with very long telomeres, yet they too are sensitive to DNAsage of irradiation in Gy. Error bars indicate standard deviation. (C) Plot of survival
 graphs), and (D), plot of the survival fraction (SF) as a function of average telomere
cross a similar range of telomere lengths in independent experimental series.damage [31], and ALT-like characteristics have been observed in
normal cells with long telomeres [10,32,33]. Possible explanations
for the problematic nature of long telomeres after irradiation are an
increase in stalled forks or DSBs within the telomeric tract after DNA
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amage, the inherent irreparability of telomeric DNA that might be
ccentuated after DNA damage [34,35], or the potential for limiting
vailability of factors that protect telomeres from a DDR (e.g. TRF2)
36] or that promote replication fork restart, C-strand ﬁll-in, and
he repair of single-stranded DNA, such as CST (CTC1, STN1, TEN1)
37–41]. Indeed, replication stress and a deﬁciency in DSB repair
as been cited as an explanation for the high rate of telomere loss
bserved in human cancer cells [4]; these deﬁciencies may  become
nsurmountable in cancer cells with very long telomeres that are
urdened with a signiﬁcant induction of DSBs.
The deleterious effects of long telomeres on cell growth and
NA damage resistance has also been documented in other orga-
isms such as Kluyveromyces lactis, Tetrahymena thermophila, and
rabidopsis thaliana, although in these instances there were con-
omitant mutations in genes encoding the telomerase RNA or the
NA repair proteins Ku70 or Mre11, which may  complicate the
irect relationship between the phenotype and the long telomeres
hemselves [42–48]. Our data suggest that very long telomeres may
lso be deleterious to human cancer cells when subjected to irra-
iation. It will be interesting to determine the mechanisms that
ncrease the irradiation sensitivity of cells with long telomeres, and
hether this is a general feature of human cancers.
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